Meeting Banner
Abstract #0241

Integrated PET/MRI with 68Ga-DOTATOC in Patients with Neuroendocrine Tumors - First Results.

Karsten Beiderwellen1, Thorsten D. Poeppel2, Verena Hartung-Knemeyer2, Christian Buchbender3, Hilmar Kuehl1, Andreas Bockisch2, Thomas C. Lauenstein1

1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany; 2Clinic for Nuclear Medicine, University Hospital Essen, Essen, Germany; 3Department of Diagnostic and Interventional Radiology, University Hospital Dusseldorf, Dusseldorf, Germany

The current goldstandard in diagnostic imaging consists of PET/CT with somatostatin-analogues such as 68Ga-DOTATOC. Due to the superb soft tissue contrast of MRI and the tendency towards early liver metastases, promising results on retrospective PET-MRI-fusion have been suggested for NETs. Since this method is time consuming and often defective, it is rarely performed in clinical routine. This is the first study on integrated PET/MRI with 68Ga-DOTATOC demonstrating its potential in whole-body staging of NETs, especially in the detection of NET liver metastases.